ライフサイエンスコーパス: phenylarsine oxide

1 by trivalent arsenicals such as arsenite and phenylarsine oxide.

2 ivity of this enzyme to the oxidizing agent, phenylarsine oxide.

3 meating, vicinal cysteine-bridging arsenical phenylarsine oxide.

4 bited by the tyrosine phosphatase inhibitor, phenylarsine oxide.

5 nosine, but are insensitive to wortmannin or phenylarsine oxide.

6 by inhibition with the endocytosis inhibitor phenylarsine oxide.

7 co-treatment of PL with NF-kappaB inhibitor phenylarsine oxide (0.1 muM) or p50 siRNA (100 nM) augme

8 in and was inhibited by tetanus toxin and by phenylarsine oxide, a phosphoinositide kinase inhibitor.

9 Prior treatment of Jurkat cells with phenylarsine oxide, a PTPase inhibitor, inhibited ameba-

10 Treatment of these cells with phenylarsine oxide, a tyrosine phosphatase inhibitor, in

11 Phenylarsine oxide, a tyrosine phosphatase inhibitor, re

12 region within which any cysteine introduced phenylarsine oxide activation to mutant TRPV1.

13 R proteins with As(III) was examined using a phenylarsine oxide affinity resin.

14 th the phosphotyrosine phosphatase inhibitor phenylarsine oxide also enhanced insulin-activated tyros

15 tive alkylating agents, N-ethylmaleimide and phenylarsine oxide, also blocked maturation and release

16 econd phosphotyrosine phosphatase inhibitor, phenylarsine oxide, also stimulates a similar cleavage o

17 Treating embryos with phenylarsine oxide, an inhibitor of endocytosis, prevent

18 of K05-138 was reduced approximately 40% by phenylarsine oxide, an inhibitor of endocytosis.

19 olae to the cytoplasm and was not blocked by phenylarsine oxide, an inhibitor of receptor-mediated en

20 and INT reductase activity are inhibited by phenylarsine oxide, an inhibitor of the activation of th

21 The fast hypopeak was not inhibited by phenylarsine oxide and appears to involve a different io

22 These changes were inhibited by phenylarsine oxide and are likely to involve the same ch

23 rt the cocrystal structures of FB bound with phenylarsine oxide and Cd(2+), two known inhibitors of t

24 erization of TRPV1 subunits upon exposure to phenylarsine oxide and hydrogen peroxide (H(2)O(2)), two

25 temperature-induced and is inhibited by both phenylarsine oxide and pertussis toxin treatment.

26 nor did the tyrosine phosphatase inhibitors phenylarsine oxide and sodium orthovanadate.

27 tion, inhibition of Jurkat cell PTPases with phenylarsine oxide blocked Jurkat cell apoptosis induced

28 ed mitochondria associated with both DCA and phenylarsine oxide by > 40 and 50%, respectively (P < 0.

29 r absence of either t-butyl hydroperoxide or phenylarsine oxide in comparison with wild-type litterma

30 Finally, phenylarsine oxide inhibited strengthening of cytoskelet

31 diated endocytosis inhibitors amantadine and phenylarsine oxide inhibited the binding and uptake of P

32 PTPase inhibitors, such as pervanadate or phenylarsine oxide, inhibited hot spot dispersal.

33 Phenylarsine oxide inhibits both O2- generation and INT

34 mbinant DLCs were specifically eluted from a phenylarsine oxide matrix with beta-mercaptoethanol indi

35 helerythrine and phosphatase inhibition with phenylarsine oxide on the baseline perfusion pressure of

36 vention of cellular receptor processing with phenylarsine oxide or chronic potassium depletion.

37 as to phenylarsenite [PhAs(III), also called phenylarsine oxide or PAO].

38 hibition of tyrosine phosphatase activity by phenylarsine oxide or sodium orthovanadate shifted ventr

39 assays by examining the cytotoxic effects of phenylarsine oxide (PAO) and cyclophosphamide (CPA) on h

40 Treatment of cells with phenylarsine oxide (PAO) at 10 microM that blocks clathr

41 Application of 1 microm phenylarsine oxide (PAO) or 1 mm benzylphosphonic acid,

42 FlAsH (an arsenic-based fluorophore) and phenylarsine oxide (PAO) potently induce Nrf2 target gen

43 Phenylarsine oxide (PAO), a strong oxidant and a prototy

44 Phenylarsine oxide (PAO), a trivalent arsenical that int

45 Patch clamp studies have shown that phenylarsine oxide (PAO), an inhibitor of PTP, decreased

46 Addition of phenylarsine oxide (PAO), an inhibitor of PTP, reversibl

47 ove mentioned reagents, but was inhibited by phenylarsine oxide (PAO), and by microinjection of mRNA

48 entrations of wortmannin (WT), LY-294002, or phenylarsine oxide (PAO), three chemically distinct agen

49 Phenylarsine oxide (PAO), which covalently binds to vici

50 Other PTP inhibitors--orthovanadate and phenylarsine oxide (PAO)-inhibited PTPepsilon with IC50

51 b; the former is preferentially inhibited by phenylarsine oxide (PAO).

52 rs of endocytosis: concanavalin A (conA) and phenylarsine oxide (PAO).

53 died the membrane-permeable arsenic compound phenylarsine oxide (PAO).

54 ne phosphatase inhibitors (pervanadate [PV], phenylarsine oxide [PAO]) and a serine-threonine phospha

55 sition (MPT) in de-energized mitochondria by phenylarsine oxide (PheArs) is greater than that by diam

56 n of PtdIns(4,5)P2 synthesis by quercetin or phenylarsine oxide prevented the relocalization of the f

57 r, lactacystin, MG132, arsenic trioxide, and phenylarsine oxide reverse the protection against growth

58 treated with the oxidizing agents diamide or phenylarsine oxide, S6K1 phosphorylation increased and b

59 sphatase (PTP) inhibitors, orthovanadate and phenylarsine oxide, selectively block mGluR-LTD induced

60 ion of one of these Cys residues reduced the phenylarsine oxide sensitivity of the enzyme to the same

61 With respect to phosphatases, phenylarsine oxide significantly increased perfusion pre

62 rsD is released from the ars DNA promoter by phenylarsine oxide, sodium arsenite, and potassium antim

63 of 1.64 microM; the known PTPase inhibitors phenylarsine oxide, sodium vanadate, and iodoacetate als

64 he purified on the basis of its affinity for phenylarsine oxide suggesting that the predicted redox-s

65 roethyl)-1-nitrosourea (BCNU), arsenite, and phenylarsine oxide) support this conclusion.

66 reatment with the vicinal-thiol cross-linker phenylarsine oxide, there was a dramatic increase in bul

67 Phenylarsine oxide was shown to be as effective as or mo

68 rk were all prevented by one such inhibitor, phenylarsine oxide, which added to closed stomata promot

69 the Y2 receptor significantly inhibited, by phenylarsine oxide, which also unmasked spare cell-surfa

70 In addition, phenylarsine oxide, which blocks angiotensin receptor in

71 volved reaction with an alternative inducer, phenylarsine oxide, which can form only two coordination